Exclusive Content
MHRA approves Colonis’s Melatonin to treat sleep onset insomnia in children
Colonis, a subsidiary company of the Clinigen Group has received the Medicines and Healthcare products Regulatory Agency (MHRA) approval for Melatonin 1mg/ml Oral Solution...
Limited supply of ‘Dioralyte oral rehydration sachets’ expected until December
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Dioralyte oral rehydration sachets.
“Dioralyte oral rehydration sachets are expected to...
Margin delivery rate increases from October
The Pharmaceutical Services Negotiating Committee (PSNC) has announced that the margin delivery rates will increase from October as the agreed £100m write-off is implemented.
“The...
Regulators reduce required notice periods for changing supplementary hours
The regulators have reduced the notice periods for change to supplementary opening hours for community pharmacy contractors from 1 October 2022.
Following the Pharmaceutical Services...
GPhC received 25 whistleblowing disclosures in a year
The General Pharmaceutical Council (GPhC) has revealed it has received 25 whistleblowing disclosures between April 2021 and March 2022.
The pharmacy regulator said, in its...
MHRA appoints Dekra to certify medical devices in UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed Dekra to certify medical devices in the UK.
Dekra Certification UK has joined the three...